We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01429883
Recruitment Status : Completed
First Posted : September 7, 2011
Last Update Posted : June 3, 2015
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the investigators want to ask for pain, pain reduction and function.

Condition or disease Phase
Fasciitis, Plantar Achillodynia Periarthritis Calcarea Epikondylopathia Humeri /Radii Phase 4

Detailed Description:
Patients with either Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get a shock wave therapy in our clinic of rheumatology as planned. During our study the investigators ask for pain, pain reduction and function (all questionnaires).

Study Design

Study Type : Observational
Actual Enrollment : 36 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?
Study Start Date : July 2011
Primary Completion Date : January 2015
Study Completion Date : January 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Shock
U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii, who got the shock wave therapy.
Criteria

Inclusion criteria:

-Patients with:

  • Fascititis plantaris,
  • Achillodynie,
  • Periarthropathia humerosacpularis calcarea or
  • Epicondylopathia humeri /radii, who got the shock wave therapy.

Exclusion criteria:

  • Anticoagulation,
  • Sepsis
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01429883


Locations
Switzerland
University Hospital
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
Principal Investigator: Sandra Blumhardt, MD University Hospital Zurich, Division of Rheumatology
More Information

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01429883     History of Changes
Other Study ID Numbers: ESWTRUZ01
First Posted: September 7, 2011    Key Record Dates
Last Update Posted: June 3, 2015
Last Verified: May 2015

Additional relevant MeSH terms:
Fasciitis
Fasciitis, Plantar
Periarthritis
Musculoskeletal Diseases
Foot Diseases
Arthritis
Joint Diseases
Bursitis